Volume 78; Issue 8

Main
Drugs
Volume 78; Issue 8

Drugs

Volume 78; Issue 8

1

Tildrakizumab: First Global Approval

Markham, Anthony

Journal:

Year:

2018

Language:

english

File:

PDF, 432 KB

english, 2018

2

Treatment of Eosinophilic Granulomatosis with Polyangiitis: A Review

Raffray, Loïc, Guillevin, Loïc

Journal:

Year:

2018

Language:

english

File:

PDF, 1.05 MB

english, 2018

3

Authors’ Reply to Pires et al.: “Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes”

Cohen, Hillel P., Blauvelt, Andrew, Rifkin, Robert M., Danese, Silvio, Gokhale, Sameer B., Woollett, Gillian

Journal:

Year:

2018

Language:

english

File:

PDF, 362 KB

english, 2018

4

Comment on: “Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes”

Pires, Antonio, Goyal, Kavitha, Greenspan, Andrew

Journal:

Year:

2018

Language:

english

File:

PDF, 352 KB

english, 2018

5

Colorectal Cancer: Why Does Side Matter?

Gallois, Claire, Pernot, Simon, Zaanan, Aziz, Taieb, Julien

Journal:

Year:

2018

Language:

english

File:

PDF, 948 KB

english, 2018

6

Correction to: Latanoprostene Bunod Ophthalmic Solution 0.024%: A Review in Open-Angle Glaucoma and Ocular Hypertension

Hoy, Sheridan M.

Journal:

Year:

2018

Language:

english

File:

PDF, 326 KB

english, 2018

7

Mirabegron: A Review in Overactive Bladder Syndrome

Journal:

Year:

2018

Language:

english

File:

PDF, 558 KB

english, 2018

8

Correction to: Ibalizumab: First Global Approval

Markham, Anthony

Journal:

Year:

2018

Language:

english

File:

PDF, 330 KB

english, 2018